Table 5

- Correlation between patients’ personal and clinical data with different quality of life domains in the QOLIE-31 Survey.

VariablesSeizure worryOverall quality of lifeEmotional well-beingEnergy/FatigueCognitiveMedication effectSocial functionQOLIE-31 score
Gender
P-value0.1210.4610.0920.028a0.6440.016a0.003a0.029a
Marital status
P-value0.1630.3360.3580.2550.8710.1480.0670.166
Employment
P-value0.8140.9840.5900.9280.9560.2430.023a0.597
Education
P-value0.7610.6230.5230.7050.7940.4380.0690.754
Type of seizure
P-value0.0920.8730.3840.4130.7780.9600.4620.824
Duration of epilepsy
P-value0.9530.4270.3290.7270.5170.8500.3620.358
Number of current ASMs
P-value0.5450.7210.7420.8130.8580.9780.4960.873
Seizure frequency
P-value0.1510.2530.012a0.2400.2490.7360.0980.146
  • ↵a Significant when using one-way ANOVA at <0.05,

  • b Using Games-Howell nonparametric post-hoc test, ASM - antiseizure medications